Florida Cannabis Regulations

Regulatory Agency: Office of Medical Marijuana Use (OMMU)  ·  Regulations checked: March 26, 2026

Florida Cannabis Regulations Overview 2026

Florida operates a medical-only cannabis program established through Amendment 2, which voters approved in November 2016 with 71% support. The program is administered by the Florida Office of Medical Marijuana Use (OMMU), a division of the Florida Department of Health. Florida's medical marijuana program is governed primarily by Chapter 381.986, Florida Statutes, and associated rules under 64ER emergency rules and permanent Rule 64-4, Florida Administrative Code.

Florida employs a vertical integration model, meaning licensed operators—known as Medical Marijuana Treatment Centers (MMTCs)—must control the entire supply chain from cultivation and processing through dispensing. As of 2026, the state has issued a limited number of MMTC licenses, creating one of the most consolidated cannabis markets in the United States. Patients must obtain a recommendation from a qualified physician and register with the OMMU to receive a Medical Marijuana Use Registry Identification Card.

The Florida market serves over 800,000 registered patients, making it one of the largest medical cannabis programs in the nation. Products available include smokable flower (permitted since 2019 following legislative action), oils, tinctures, capsules, topicals, edibles, and suppositories. THC caps have been a recurring legislative topic, though no permanent statutory cap has been enacted as of early 2026.

Packaging Requirements for Cannabis Products in Florida 2026

Florida imposes strict packaging requirements on all medical marijuana products dispensed by MMTCs. These requirements are designed to ensure product safety, prevent diversion, and protect vulnerable populations including children.

Child-Resistant Packaging

• All medical marijuana products must be dispensed in child-resistant packaging that meets the standards set by the U.S. Consumer Product Safety Commission under 16 CFR 1700
• Packaging must be designed to be significantly difficult for children under five years of age to open within a reasonable time
• Re-sealable containers must maintain child-resistant properties after initial opening
• Single-dose edible products must each be individually packaged in child-resistant packaging

Tamper-Evident Requirements

• All packaging must be tamper-evident, providing visible indication if the package has been opened or compromised
• Tamper-evident seals must be applied at the point of final packaging by the MMTC
• Patients should be instructed not to accept products with broken or missing tamper-evident features

Opaque and Plain Packaging

• Packaging must not be attractive to children and must not contain images of cartoons, celebrities, or any design elements that could appeal to minors
• Product packaging should be plain in design and must not mimic conventional food products or candy
• Edible products in particular may not be manufactured in shapes resembling animals, people, or fruit

Labeling Requirements for Medical Marijuana in Florida 2026

Florida's labeling requirements for medical marijuana products are detailed and must be followed precisely by all MMTCs. Labels serve as the primary source of product information for patients and caregivers.

Required Label Information

• Name and license number of the MMTC that produced and dispensed the product
• Product name and unique batch/lot number for traceability
• THC and CBD content expressed in milligrams per dose and total milligrams per container
• Net weight or volume of the product
• Date of manufacture, harvest, or processing and an expiration or use-by date
• Patient's name and registry identification number
• Recommending physician's name and license number
• Directions for use, including recommended dosage
• Route of administration (oral, inhalation, topical, etc.)
• List of all ingredients, including inactive ingredients and potential allergens

Warning Statements

• "For medical use only" must appear prominently
• "Keep out of reach of children" warning is mandatory
• "This product may impair your ability to drive or operate heavy machinery" must be included
• Universal cannabis symbol must be displayed on the label
• Warning regarding use during pregnancy or breastfeeding

Barcode and Tracking Requirements

• Each product must bear a scannable barcode or QR code linked to the state seed-to-sale tracking system
• The tracking identifier must correspond to data in the Medical Marijuana Use Registry

Exit Bag Requirements in Florida 2026

Florida requires that medical marijuana products be provided to patients in compliant exit packaging when dispensed at MMTC dispensary locations. Exit bags serve as an additional layer of child safety and discretion.

• All dispensed products must leave the dispensary in an opaque, child-resistant exit bag
• Exit bags must meet ASTM D3475 child-resistant standards or equivalent CPSC certification
• The bag must be sealed before the patient exits the dispensary premises
• Exit bags must be plain and may not contain marketing imagery or branding beyond the MMTC's basic logo and required regulatory text
• Some MMTCs use locking exit bags with zipper mechanisms that require coordinated squeezing to open
• Exit bags are provided at no additional cost to the patient

Advertising and Marketing Rules for Medical Cannabis in Florida 2026

Advertising and marketing of medical marijuana in Florida is heavily regulated under Section 381.986, Florida Statutes, and OMMU rules. The intent is to ensure marketing is directed at qualified patients and does not promote recreational use or appeal to minors.

Permitted Advertising

• MMTCs may advertise through print, digital, broadcast, and signage channels provided the content is truthful and not misleading
• All advertisements must include the MMTC license number and a warning that the product is for medical use only
• Marketing materials may describe available product types, MMTC locations, and general patient qualification information
• Website advertising is permitted and must include age-gating mechanisms

Prohibited Advertising Practices

• No advertising may target or be designed to appeal to individuals under 21 years of age
• Advertisements may not include images of cannabis leaf or plant in a way that glamorizes use
• Use of cartoon characters, celebrity endorsements (unless the celebrity is a registered patient), or mascots is prohibited
• Price discounting and "happy hour" style promotions are restricted
• Advertising within 1,000 feet of schools, daycare centers, churches, and playgrounds is prohibited
• Pop-up or unsolicited digital advertisements are not permitted
• Claims of specific medical benefits or curative properties are prohibited unless supported by FDA-approved research

Promotional Product Rules for Medical Cannabis in Florida 2026

The distribution of promotional products and branded merchandise by MMTCs in Florida is subject to restrictions designed to prevent the normalization of cannabis use and to keep branding away from minors.

• Branded merchandise such as hats, t-shirts, lighters, and bags may be distributed to registered patients inside dispensary locations
• Promotional items may not be distributed to the general public or at events open to persons under 21
• Promotional items must not contain imagery that appeals to minors (cartoons, bright colors designed to attract children, toy-like designs)
• Free product samples of medical marijuana are prohibited—only compliant products dispensed per a physician's recommendation are permitted
• Patient loyalty programs and point-based reward systems are permitted but may not be advertised outside the dispensary
• Promotional materials must include the MMTC's license number and medical-use-only language
• Branded rolling papers, grinders, and accessories may be sold at dispensaries but may not feature cannabis leaf imagery on external packaging visible from outside the store

Testing and Laboratory Requirements in Florida 2026

Florida requires all medical marijuana products to undergo comprehensive laboratory testing before being dispensed to patients. Testing is performed by certified laboratories approved by the OMMU.

Required Testing Panels

• Potency Analysis: THC, THCA, CBD, CBDA, and total cannabinoid profile
• Residual Solvents: Testing for butane, propane, ethanol, and other extraction solvents
• Pesticide Screening: Panel of prohibited pesticides per OMMU-approved list
• Heavy Metals: Lead, arsenic, cadmium, and mercury at specified action levels
• Microbial Contaminants: Total yeast and mold, E. coli, Salmonella, and Aspergillus species
• Mycotoxins: Aflatoxin B1, B2, G1, G2 and ochratoxin A
• Moisture Content: Particularly for flower products to prevent mold growth
• Foreign Material: Visual and microscopic inspection for hair, insects, and other contaminants

Laboratory Certification

• Laboratories must be certified by the OMMU and demonstrate ISO 17025 accreditation or equivalent
• Labs must participate in proficiency testing programs
• Results must be reported to the OMMU tracking system within a specified timeframe
• MMTCs may not own or have financial interest in testing laboratories to prevent conflicts of interest

Licensing Overview for Medical Marijuana in Florida 2026

Florida's licensing structure for medical marijuana is unique due to its vertical integration mandate. Only MMTCs hold licenses, and each license covers the full spectrum of operations.

MMTC License Requirements

• Applicants must have been registered as a nursery with the Florida Department of Agriculture for at least 30 continuous years (original requirement, though additional licenses have been issued through litigation and legislative changes)
• Applicants must demonstrate sufficient financial resources, a detailed business plan, and the ability to maintain operations across cultivation, processing, and dispensing
• Background checks are required for all owners, officers, directors, and managers
• Each MMTC may operate up to a set number of dispensary locations statewide (limits have been adjusted over time through regulatory and legal actions)
• Annual license renewal fees apply, and MMTCs must demonstrate ongoing compliance

Patient and Caregiver Registration

• Patients must be Florida residents with a qualifying medical condition diagnosed by a qualified physician
• Qualifying conditions include cancer, epilepsy, glaucoma, PTSD, ALS, Crohn's disease, Parkinson's disease, MS, and other debilitating conditions
• Caregivers must pass a Level 2 background screening and be registered with the OMMU
• Patient ID cards are valid for one year and must be renewed along with physician certifications

Cannabis Taxes in Florida (2026)

Florida cannabis businesses collect and remit multiple overlapping taxes. Below is a summary of the rates that apply to retail cannabis sales as of 2026. Regulatory agency: Florida Office of Medical Marijuana Use (OMMU).

• Excise tax: No cannabis excise tax
• Sales tax: Medical cannabis is exempt from Florida state sales tax per the 2016 constitutional amendment
• Local cannabis tax: No additional local cannabis tax
• Medical exemption: Florida operates a medical-only program; all purchases by qualified patients are tax-free
• Effective combined rate: 0% medical (fully tax-exempt)

Florida has the largest medical cannabis program in the US by patient count, and one of the few with no state taxes on medical purchases.

Frequently Asked Questions

Browse by Regulation Category

Check Neighboring States

Alabama · Georgia

Explore Florida Cannabis